DYN earnings: a negative outcome, -5.9%

On March 4, 2021, Dyne Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.9% in the window around the event. It had already run -12.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.